Orpyx Medical Technologies’ sensory insoles, analytics platform, and remote monitoring program will be used in a new clinical trial funded by the National Institutes of Health.
The Wearable Insoles for Recurrent Diabetic Ulcer Prevention (WIREDUP) study will be led by Johns Hopkins University School of Medicine, with collaborators from Keck Medicine of the University of Southern California and the University of Utah Spencer Fox Eccles School of Medicine.
The $5 million randomized controlled trial will enroll 400 participants to test whether integrating digital foot monitoring into routine care can help reduce the incidence of diabetic foot ulcers.
Orpyx is providing the digital health platform for the study, which includes sensory insoles to capture plantar pressure, temperature, and activity data; analytics to identify patterns of concern; and a remote monitoring program to enable timely escalation of care. Study oversight, data collection, and analysis will remain entirely with the independent academic research team.
